For laboratory research use only · Not for human or veterinary use · 18+
Kits, stacks and value packs

Buy Retatrutide Pen Kit 20mg in Australia

Retatrutide 20mg pre-filled pen, 20 pen needles and 20 alcohol swabs · Available to order, dispatched from Australia
$285.99

Buy the Retatrutide pen kit 20mg in Australia from Macropus Peptides: a pre-filled pen holding 20 milligrams of Retatrutide already in solution, packed with 20 pen needles and 20 alcohol swabs. Because the peptide is dissolved at filling, there is no powder to reconstitute and no diluent to measure, which suits laboratories that want a consistent, ready solution. The pen label shows compound, amount, lot number and storage temperature, and the certificate of analysis for the lot is available on request. The whole kit costs less than the 20mg pen bought on its own, so the needles and swabs come at no extra charge. Keep the pen refrigerated at 2 to 8 °C and never frozen. Orders are posted from our Australian shelves nationwide to buyers aged 18 and over, for in-vitro laboratory research only and not for human or veterinary use.

1
Frequently bought together
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
KitRetatrutide pen kit 20mg
Amountpen kit
FormResearch kit
ContentsRetatrutide 20mg pre-filled pen, 20 pen needles and 20 alcohol swabs
CategoryKits, stacks and value packs
StorageSee label
TestingHPLC purity 98% or higher and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label

Buy Retatrutide Pen Kit 20mg Australia: Pen, Needles and Swabs

The 20mg pen kit packages our pre-filled triple agonist pen with the consumables that go with it. Instead of ordering a pen, a box of needles and a pack of swabs as three lines, one order brings all of them, and the combined price comes in below the 20mg pen on its own. The peptide arrives already in solution, so there is nothing to reconstitute.

What is in the Retatrutide pen kit

  • One pre-filled pen, 20 milligrams in solution
  • 20 screw-on pen needles
  • 20 alcohol swabs

The pen carries an investigational lipidated peptide, catalogued as LY3437943 while in development, whose single chain reaches three metabolic hormone receptors. It is in phase 3 clinical development and is not an approved medicine. The pen label shows compound, total amount, fill volume, lot code and storage temperature, and the format is covered in detail on the single pen listing.

Retatrutide pen: how the compound works in research

The peptide imitates three hormones at once. Two of those signals, GLP-1 and GIP, come from intestinal cells after food and amplify insulin release only while glucose is elevated, and the GLP-1 arm also holds food in the stomach for longer. Glucagon, from the pancreas, acts mainly on the liver, raising glucose output and fat oxidation. By engaging all three receptors, with its highest potency at GIP, the molecule lets a laboratory ask what the glucagon signal adds to incretin activity. Its albumin-binding lipid chain and protected backbone keep it circulating for days, which is why it is often studied against shorter-acting comparators.

Retatrutide clinical trials: from first description to phase 3

The evidence base moves through the usual stages of drug development. Preclinical chemistry and a first-in-human study were reported together in Cell Metabolism in 2022. The Lancet carried the phase 1b work in type 2 diabetes that year. Two phase 2 reports followed in 2023, covering obesity and diabetes populations in separate journals, and a liver fat analysis came in Nature Medicine in 2024. Phase 3 trials are still under way and have not reported. Every paper is listed in our Retatrutide research studies library; none of them concerns the pen as a format.

Pen kit specifications: Retatrutide 20mg

SpecificationDetail
KitRetatrutide pen kit 20mg
Amountpen kit
FormResearch kit
ContentsRetatrutide 20mg pre-filled pen, 20 pen needles and 20 alcohol swabs
CategoryKits, stacks and value packs
StorageSee label

The kit ships as a single carton. The pen needles are sterile and single use, and the swabs are for wiping the pen septum before each needle is fitted and for small areas of bench.

Retatrutide pen price against the parts

OptionPrice
Retatrutide pen kit 20mg$285.99

This kit is priced below the 20mg pen by itself, so the needles and swabs effectively come free. Priced item by item (pen, one 20 pack of pen needles and a box of alcohol swabs) the same contents would cost about one fourteenth more. Milligram for milligram the pen still sits above the dry 20mg vial, the cost of preparing and chilling a finished solution.

Retatrutide 20mg pre-filled pen: what you buy

A dial body holds the glass cartridge, and all 20 milligrams are dissolved before the pen is sealed and labelled, so the working concentration never changes between users. It is the mid-size pen in our range, between the 15mg and 30mg strengths, and the pen body is single use: it is not refilled when empty.

Pen needles and swabs: the Retatrutide kit supplies

The 20 needles are 32 gauge and 4 mm long, with the common screw thread that fits the pen tip. Each is sealed in its own sterile container under a paper tab, and each is fitted fresh for one session, then removed. The 20 swabs are pre-moistened isopropyl pads for cleaning the cartridge septum before a needle goes on. A refill of both costs little, and a box of 20 needles matches the kit count exactly.

Where to buy the Retatrutide 20mg pen in Australia

  • Sold online at macropuspeptides.com, priced at $285.99
  • Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
  • A certificate of analysis for every lot, matched to the lot number printed on the label
  • Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
  • Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
  • Payment by PayID or bank transfer, with your order ID as the reference

How to get Retatrutide: ordering the pen kit online

  • Add the 20mg pen kit
  • Consider a sharps container
  • Check the delivery address
  • Complete the research declaration
  • Refrigerate the pen on arrival

Retatrutide pen handling: no bac water needed

Because the solution is prepared at filling, there is no diluent to add and no concentration to calculate, and the figure on the label is the one to plan around. That removes one preparation step and a source of variation between operators. By contrast, a freeze-dried 20mg vial must be mixed first: 2 mL of bacteriostatic water makes 10 mg per mL, while 4 mL settles at 5 mg per mL. What the pen asks for instead is an unbroken cold chain: keep it capped in a fridge between 2 and 8 °C, shielded from light and never frozen, store it without a needle attached, and drop each used needle into a rigid sharps container.

Is Retatrutide available in Australia as a pen

Only as research material. A pen format leaves the regulatory picture unchanged: the compound is absent from the ARTG, unassessed by the TGA, and sold by us strictly for in-vitro laboratory work. Scheduling questions under the Poisons Standard are for each organisation to settle before it buys.

Retatrutide pen kit for sale Australia wide: related formats

Each kit is packed cold at our Australian facility and dispatched to metro and country postcodes in every state. Labs wanting more peptide in the same format can step up to the 30mg pen kit, while those comfortable with reconstitution will find the freeze-dried vials cheaper per milligram and longer lasting in a freezer. More bundles are in peptide kits, and consumables in lab supplies.

References

  1. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metabolism. 2022;34(9):1234-1247.
  2. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. New England Journal of Medicine. 2023;389(6):514-526.
  3. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. The Lancet. 2022;400(10366):1869-1881.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Questions about Retatrutide pen kit 20mg

Chat on WhatsApp
Retatrutide pen kit 20mg$285.99